BridgeMD
New treatment option for Breast Cancer
Official title A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
ClinicalTrials.gov ID: NCT07335354
What this study is testing
- What it's testing
- The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant Focus Group Participants
- A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the...
- ≥18 years old
- Considering post-mastectomy breast reconstruction RCT Participants (Patients)
- A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the...
You likely can't join if
- Focus Group Participants
- Not considering post-mastectomy breast reconstruction
- Non-English proficiency RCT Participants (Patients)
- Not considering postmastectomy breast reconstruction
- Recurrent or metastatic breast cancer
- Male sex
See the full eligibility criteria
- Participant Focus Group Participants
- A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
- ≥18 years old
- Considering post-mastectomy breast reconstruction RCT Participants (Patients)
- A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
- ≥18 years old
- Considering post-mastectomy breast reconstruction
- Have an appointment scheduled for consultation with a plastic surgery provider RCT Participants (Physicians)
- Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery. Participant
- Focus Group Participants
- Not considering post-mastectomy breast reconstruction
- Non-English proficiency RCT Participants (Patients)
- Not considering postmastectomy breast reconstruction
- Recurrent or metastatic breast cancer
- Male sex
- Non-English proficiency RCT Participants (Physicians)
- Does not provide breast reconstruction care at least 50% of the time
- Non-English proficiency
The study team makes the final eligibility decision.
Where it's taking place
- Basking Ridge, New Jersey, United States
- Middletown, New Jersey, United States
- Montvale, New Jersey, United States
- Commack, New York, United States
- Harrison, New York, United States
- New York, New York, United States
- Rockville Centre, New York, United States
- Durham, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basking Ridge, New Jersey, United States; Middletown, New Jersey, United States; Montvale, New Jersey, United States; Commack, New York, United States; Harrison, New York, United States; New York, New York, United States and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.